» Articles » PMID: 21993013

Importance of Vascular Endothelial Growth Factor (VEGF) in Ovarian Physiology of Mammals

Overview
Journal Zygote
Date 2011 Oct 14
PMID 21993013
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Ovarian folliculogenesis in mammals is a complex process. Several compounds have been tested during in vitro culture of follicular cells for a better understanding of the mechanisms and factors related to ovarian folliculogenesis in mammals. From these compounds, vascular endothelial growth factor (VEGF) can be highlighted, as it is strongly associated with angiogenesis and, in recent years, its presence in ovarian cells has been investigated extensively. Previous studies have shown that the presence of VEGF protein, as well as mRNA expression of its receptor 2 (VEGFR-2) increases during follicular development. Therefore, it is likely that the interaction between VEGF and VEGFR-2 is crucial to promote follicular development. However, few studies on the influence of this factor on follicular development have been reported. This review addresses aspects related to the structural characterization and mechanism of action of VEGF and its receptors, and their biological importance in the ovary of mammals.

Citing Articles

Effect of maceration treatment on ovarian follicular development, serum oestradiol, uterine growth and vascularisation in female albino rats.

Andriyanto A, Putra H, Subangkit M, Tarigan E, Nugrahaning Widi L, Irarang Y J Vet Res. 2024; 68(2):287-294.

PMID: 38947163 PMC: 11210355. DOI: 10.2478/jvetres-2024-0020.


Granulosa cells and follicular development: a brief review.

Cavalcanti G, Carvalho K, Ferreira C, Alvarez P, Araujo Monteleone P, Baracat E Rev Assoc Med Bras (1992). 2023; 69(6):e20230175.

PMID: 37377286 PMC: 10305830. DOI: 10.1590/1806-9282.20230175.


Age-related changes in Folliculogenesis and potential modifiers to improve fertility outcomes - A narrative review.

Esencan E, Beroukhim G, Seifer D Reprod Biol Endocrinol. 2022; 20(1):156.

PMID: 36397149 PMC: 9670479. DOI: 10.1186/s12958-022-01033-x.


Potential ovarian toxicity and infertility risk following targeted anti-cancer therapies.

Rosario R, Cui W, Anderson R Reprod Fertil. 2022; 3(3):R147-R162.

PMID: 35928672 PMC: 9346327. DOI: 10.1530/RAF-22-0020.


Equine ovarian tissue xenografting: impacts of cooling, vitrification, and VEGF.

Souza S, Aguiar F, Alves B, Alves K, Brandao F, Brito D Reprod Fertil. 2022; 2(4):251-266.

PMID: 35118403 PMC: 8801023. DOI: 10.1530/RAF-21-0008.